John Grigg

5.7k total citations · 1 hit paper
144 papers, 3.3k citations indexed

About

John Grigg is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, John Grigg has authored 144 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Ophthalmology, 54 papers in Molecular Biology and 42 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in John Grigg's work include Retinal Development and Disorders (44 papers), Retinal Diseases and Treatments (39 papers) and Glaucoma and retinal disorders (36 papers). John Grigg is often cited by papers focused on Retinal Development and Disorders (44 papers), Retinal Diseases and Treatments (39 papers) and Glaucoma and retinal disorders (36 papers). John Grigg collaborates with scholars based in Australia, United Kingdom and United States. John Grigg's co-authors include Stuart L. Graham, Alexander Klistorner, Robyn V. Jamieson, Peter McCluskey, Clare L. Fraser, Frank A. Billson, Anthony G. Robson, Shiying Li, Mineo Kondo and Ruth Hamilton and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Stroke.

In The Last Decade

John Grigg

137 papers receiving 3.2k citations

Hit Papers

ISCEV Standard for full-f... 2022 2026 2023 2024 2022 50 100 150 200 250

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
John Grigg 2.0k 1.3k 1.1k 436 332 144 3.3k
Paulus T. V. M. de Jong 3.5k 1.7× 981 0.8× 2.1k 2.0× 188 0.4× 261 0.8× 51 4.6k
Herbert A. Reitsamer 2.4k 1.2× 1.0k 0.8× 1.5k 1.5× 107 0.2× 180 0.5× 132 3.7k
Sayoko E. Moroi 2.4k 1.2× 666 0.5× 1.5k 1.4× 271 0.6× 203 0.6× 99 3.1k
Atsushi Mizota 1.6k 0.8× 1.0k 0.8× 818 0.8× 75 0.2× 116 0.3× 158 2.7k
William H. Morgan 3.5k 1.7× 835 0.7× 2.3k 2.2× 136 0.3× 453 1.4× 153 4.3k
Eiko K. de Jong 1.7k 0.9× 950 0.8× 1.1k 1.1× 355 0.8× 53 0.2× 70 3.1k
Stephen G. Schwartz 2.4k 1.2× 601 0.5× 1.5k 1.4× 105 0.2× 93 0.3× 157 3.3k
N. Orzalesi 3.2k 1.6× 866 0.7× 2.0k 1.9× 89 0.2× 315 0.9× 120 4.0k
Kei Shinoda 2.6k 1.3× 1.5k 1.2× 1.5k 1.4× 117 0.3× 57 0.2× 219 3.8k

Countries citing papers authored by John Grigg

Since Specialization
Citations

This map shows the geographic impact of John Grigg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Grigg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Grigg more than expected).

Fields of papers citing papers by John Grigg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Grigg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Grigg. The network helps show where John Grigg may publish in the future.

Co-authorship network of co-authors of John Grigg

This figure shows the co-authorship network connecting the top 25 collaborators of John Grigg. A scholar is included among the top collaborators of John Grigg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Grigg. John Grigg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Broadhead, Geoffrey, John Grigg, Peter McCluskey, et al.. (2024). Saffron therapy for the ongoing treatment of age-related macular degeneration. BMJ Open Ophthalmology. 9(1). e001399–e001399. 3 indexed citations
3.
Britten‐Jones, Alexis Ceecee, Myra B. McGuinness, Fred K. Chen, et al.. (2024). A multinational survey of potential participant perspectives on ocular gene therapy. Gene Therapy. 31(5-6). 314–323. 3 indexed citations
4.
McGuinness, Myra B., Lauren N. Ayton, Deborah Schofield, et al.. (2024). EQ‐5D‐5L health utility scores in Australian adults with inherited retinal diseases: A cross‐sectional survey. Acta Ophthalmologica. 102(5). e736–e745. 3 indexed citations
5.
Jamieson, Robyn V., et al.. (2024). Managing the apparently blind child presenting in the first year of life: A review. Clinical and Experimental Ophthalmology. 52(4). 452–463.
6.
Simunovic, Matthew P., Anthony T. Moore, John Grigg, et al.. (2024). THE FIGHT INHERITED RETINAL BLINDNESS! PROJECT. Retina. 45(2). 286–295. 1 indexed citations
7.
Crofts, Stephanie, et al.. (2023). Spectrum of ocular disease in children aged between 0 and 3 years at an Australian paediatric tertiary hospital. Clinical and Experimental Ophthalmology. 51(6). 546–558. 2 indexed citations
8.
Constable, Paul A., et al.. (2023). Suspected case of benign familial fleck retina with functional loss. SHILAP Revista de lepidopterología. 11(12). e8362–e8362. 1 indexed citations
9.
Mack, Heather G., Alexis Ceecee Britten‐Jones, Myra B. McGuinness, et al.. (2022). Survey of perspectives of people with inherited retinal diseases on ocular gene therapy in Australia. Gene Therapy. 30(3-4). 336–346. 8 indexed citations
10.
Nash, Benjamin M., Alan Ma, Gladys Ho, et al.. (2022). Whole Genome Sequencing, Focused Assays and Functional Studies Increasing Understanding in Cryptic Inherited Retinal Dystrophies. International Journal of Molecular Sciences. 23(7). 3905–3905. 7 indexed citations
11.
Robson, Anthony G., Laura J. Frishman, John Grigg, et al.. (2022). ISCEV Standard for full-field clinical electroretinography (2022 update). Documenta Ophthalmologica. 144(3). 165–177. 290 indexed citations breakdown →
12.
Mack, Heather G., Fred K. Chen, John Grigg, et al.. (2021). Perspectives of people with inherited retinal diseases on ocular gene therapy in Australia: protocol for a national survey. BMJ Open. 11(6). e048361–e048361. 9 indexed citations
13.
Zagora, Sophia, et al.. (2021). Cataract Surgery in Short Eyes, Including Nanophthalmos: Visual Outcomes, Complications and Refractive Results. Clinical ophthalmology. Volume 15. 4543–4551. 10 indexed citations
14.
Nash, Benjamin M., Milan Fernando, James P. Robinson, et al.. (2021). Evaluation for Retinal Therapy for RPE65 Variation Assessed in hiPSC Retinal Pigment Epithelial Cells. Stem Cells International. 2021. 1–12. 4 indexed citations
15.
Grigg, John, et al.. (2020). Aqueous humor vascular endothelial growth factor concentration before and after intravitreal injection of Bevacizumab for diabetic retinopathy. Clinical ophthalmology. 4(2). 250–253. 1 indexed citations
16.
Zagora, Sophia, et al.. (2020). Surgical Management for Glaucoma in Sturge-Weber Syndrome: Experience from a Tertiary Referral Paediatric Hospital. Investigative Ophthalmology & Visual Science. 61(7). 977–977. 1 indexed citations
17.
Nash, Benjamin M., Richard J. Symes, Himanshu Goel, et al.. (2017). NMNAT1 variants cause cone and cone-rod dystrophy. European Journal of Human Genetics. 26(3). 428–433. 16 indexed citations
18.
Wechsler, David, et al.. (2013). Retrospective Review of Pars Plana Versus Anterior Chamber Placement of Baerveldt Glaucoma Drainage Device. Journal of Glaucoma. 24(2). 95–99. 28 indexed citations
20.
Klistorner, Alexander, et al.. (2000). Objective perimetry in glaucoma. Investigative Ophthalmology & Visual Science. 41(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026